Ovid Therapeutics (OVID) Prepaid Assets (2016 - 2026)

Ovid Therapeutics (OVID) has reported Prepaid Assets for 11 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Prepaid Assets rose 70.98% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $6.4 million (up 70.98% YoY), and the FY2025 full-year result was $4.7 million, up 65.2% from the prior year.
• Prepaid Assets climbed to $6.4 million in Q2 2026 per OVID's latest filing, from $4.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $6.4 million in Q2 2026 and bottomed at $1.8 million in Q1 2023.
• Historically, Prepaid Assets has averaged $3.6 million across 5 years, with a median of $3.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 108.22% in 2023, then sank 32.89% in 2024.
• Over 5 years, Prepaid Assets stood at $2.4 million in 2022, then soared by 58.16% to $3.8 million in 2023, then retreated by 23.86% to $2.9 million in 2024, then soared by 65.2% to $4.7 million in 2025, then surged by 35.18% to $6.4 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $6.4 million, $4.6 million, and $4.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.